Top Markets
#1 Useless Coin Useless Coin +39.98%
#2 StonkBroker StonkBroker +38.07%
#3 Merlin's Seal BTC Merlin's Seal BTC +37.69%
#4 0G 0G +34.77%
#5 SAFEcoin SAFEcoin +30.08%
#6 Dogs Dogs +19.32%
#7 Arbitrum Arbitrum +18.58%
#8 Full Moon Full Moon +17.84%
#9 Zora Zora +17.77%
#10 Notcoin Notcoin +17.21%
Coin of the day
Useless Coin Useless Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Neighbourly Pharmacy Inc. Neighbourly Pharmacy Inc.

Neighbourly Pharmacy Inc.

NBLY
Rank in Stocks #13883
Neighbourly Pharmacy Inc. is a Canadian enterprise that oversees and manages an... Neighbourly Pharmacy Inc. is a Canadian enterprise that oversees and manages an extensive chain of retail drugstores across the nation. These pharmacies provide a wide spectrum of goods, encompassing prescription drugs, various food and confectionery items, over-the-counter medicines, and personal care and cosmetic products. Operating from 275 different sites, the company's outlets are branded under several familiar names, including IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. Established in 2015, Neighbourly Pharmacy Inc. maintains its corporate headquarters in Toronto, Canada.
Share Price
$13.61
Last synced: 2024-03-22
Market Cap
$451.66M
Change (1 day)
-0.32%
Change (1 year)
0.00%
Country
CA
Trade Neighbourly Pharmacy Inc. (NBLY)

Category

Healthcare
P/E ratio for Neighbourly Pharmacy Inc. (NBLY)
P/E ratio as of 2026 TTM: 0
According to Neighbourly Pharmacy Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Neighbourly Pharmacy Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 24.32 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 31.46 -
HK
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.